Cisen Pharmaceutical Co (SHSE:603367) COGS-to-Revenue : 0.40 (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Cisen Pharmaceutical Co COGS-to-Revenue?

Cisen Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥371 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥920 Mil.

Cisen Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.40.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Cisen Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 was 59.71%.

Cisen Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Cisen Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cisen Pharmaceutical Co COGS-to-Revenue Chart

Cisen Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.43

0.45

0.44

0.41

0.43

Cisen Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.38	0.48	0.44	0.45	0.40

Cisen Pharmaceutical Co COGS-to-Revenue Calculation

Cisen Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1729.094	/	3981.572
	=	0.43

Cisen Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	370.718	/	920.204
	=	0.40

Cisen Pharmaceutical Co (SHSE:603367) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Cisen Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	370.718 / 920.204
	=	59.71 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cisen Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cisen Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cisen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cisen Pharmaceutical Co Ltd (SHSE:603367) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Tongji Sci-tech Industrial Park, High-tech Industrial Development Zone, Shandong, Jining, CHN, 272073

Website

http://www.lkcisen.com

Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.

Cisen Pharmaceutical Co Headlines

No Headlines